source
- Axsome secures settlement to keep Sunosi exclusive until 2040Axsome Therapeutics announced it has reached a settlement that pushes back the entry of generic versions of its narcolepsy medication Sunosi until 2040. The agreement was reached with the last rem…
- Bipartisan House bill would require security review of U.S. biotech investments in ChinaA bipartisan group of Representatives introduced legislation on Tuesday that would expand the Committee on Investment and National Security (COINS) Act to cover biotechnology. The bill, called the…